Docetaxel‐induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model
- 18 March 2009
- journal article
- Published by Wiley in Journal of the Peripheral Nervous System
- Vol. 14 (1) , 36-44
Abstract
Abstract Peripheral neurotoxicity is a frequent complication limiting docetaxel chemotherapy in patients with cancer. We developed an experimental model that closely mimics the course of neuropathy in patients, aiming to investigate both the mechanisms of neurotoxicity at biochemical, functional and morphological levels and the potential neuroprotective role of neuroactive steroids. We demonstrated that treatment with dihydroprogesterone (DHP) or progesterone (P) counteracts docetaxel‐induced neuropathy, preventing nerve conduction and thermal threshold changes, and degeneration of skin nerves in the foodpad. Neuroactive steroids also counteract the changes in gene expression of several myelin proteins and calcitonin gene‐related peptide induced by docetaxel in sciatic nerve and lumbar spinal cord, respectively. Most nerve abnormalities observed during the treatment with docetaxel spontaneously recovered after drug withdrawal, similarly to what occurs in patients. However, results of midterm follow‐up experiments indicated that animals cotreated with DHP or P have a faster recovery of the neuropathy compared with docetaxel‐treated rats. Our study confirmed that neuroactive steroids exert a protective effect on peripheral nerves at different levels, suggesting that they might represent a new therapeutic frontier for patients with chemotherapy‐induced neuropathy.Keywords
This publication has 41 references indexed in Scilit:
- EFNS guidelines on pharmacological treatment of neuropathic painEuropean Journal of Neurology, 2006
- Multi‐center assessment of the Total Neuropathy Score for chemotherapy‐induced peripheral neurotoxicityJournal of the Peripheral Nervous System, 2006
- Erythropoietin both protects from and reverses experimental diabetic neuropathyProceedings of the National Academy of Sciences, 2004
- Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged ratsNeurobiology of Aging, 2003
- Managing the Neurotoxicity of Paclitaxel (Taxol®) and Docetaxel (Taxotere®) with Neurotrophic FactorsCancer Investigation, 2000
- Physiological characterization of taxol‐induced large‐fiber sensory neuropathy in the ratAnnals of Neurology, 1998
- Peripheral neuropathy secondary to docetaxel (Taxotere)Neurology, 1996
- Experimental Peripheral Neuropathy Induced in Adult Rats by Repeated Intraperitoneal Administration of TaxolExperimental Neurology, 1995
- Taxol NeuropathyArchives of Neurology, 1994
- Nerve growth factor prevents experimental cisplatin neuropathyAnnals of Neurology, 1992